Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Research into Cold Cancers Heating Up

Activation and expansion are essential for success in both autologous and allogeneic therapies.

Development of Gamma-Delta T-Cell Therapies

Continuous manufacturing and a quality-by-design development approach are a natural fit.

QbD for Small-Molecule Continuous Process Development

Topic

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Videos

Pharmaceutical Technology® sat down with Kate Coleman from Arriello to run through the major trends from 2024, including the importance of technological advances, and how these may progress in 2025.

Industry Outlook 2025: Regulating Technology for the Future

Cheryl Barton is director of PharmaVision, 

Articles

European biopharma companies are looking beyond GLP-1s.

Next-Generation Anti-Obesity Medicines

In this interview, Pharmaceutical Technology® discusses the trend of AI in pharma and how it may play out in 2025 and beyond with Ben Sidders from Biorelate.

Industry Outlook 2025: The Rising Prominence of AI in Pharma

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Increasing API and formulation complexity and new delivery strategies are driving innovations in taste-masking.

Evolving Approaches to Taste Masking 

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Hood, a pioneer of systems biology and systems medicine, shared his personal interest in starting a new peptide-based, informational-driven pharmaceutical company that would address wellness and longevity.

Systems Biology Pioneer Lee Hood Talks Precision Medicine, AI in Health, and the Next Paradigm Shift 

Webcasts

Webinar Date/Time: Tues, March 4, 2025 11:00 AM EST


Nasal Drug Delivery on the Rise: What’s Next for Pharma?

The optimization of processes for the development and manufacture of biopharmaceuticals is pivotal for producing quality products. 

Steps to Process Development Optimization

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

The tariffs President Trump wants to levy against Canada and Mexico are on hold, for now, but China has already announced it intends to proceed with retaliatory tariffs against the US.

Pharmaceutical Industry Responds to Proposed Trump Administration Tariffs

Feliza Mirasol is the science editor for 

CDMOs who have integrated technologies can help further the advancement of ADC development.

Advancing ADCs to the Next Level

Mike Hennessy Jr. is the Chairman and CEO of 

If the conditions prove optimal, 2025 could be a prosperous year for bio/pharma business deals.

Drug Development

Research into Cold Cancers Heating Up

Development of Gamma-Delta T-Cell Therapies

QbD for Small-Molecule Continuous Process Development